113 related articles for article (PubMed ID: 7230332)
1. Prognostic factors in carcinoma of the ureter.
Heney NM; Nocks BN; Daly JJ; Blitzer PH; Parkhurst EC
J Urol; 1981 May; 125(5):632-6. PubMed ID: 7230332
[TBL] [Abstract][Full Text] [Related]
2. [A clinicopathological evaluation of prognostic factors of urothelial tumors of the renal pelvis and ureter].
Oikawa T; Nomura H; Kinsui H; Hamano S; Suzuki N; Tanaka M; Murakami S; Nokubi M; Suzuki Y
Hinyokika Kiyo; 2001 Apr; 47(4):237-40. PubMed ID: 11411096
[TBL] [Abstract][Full Text] [Related]
3. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
4. Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.
Inamoto T; Matsuyama H; Ibuki N; Komura K; Takahara K; Fujimoto K; Shiina H; Sakano S; Nagao K; Miyake M; Tatsumi Y; Yasumoto H; Azuma H;
J Urol; 2018 Apr; 199(4):933-939. PubMed ID: 29037861
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival.
Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
Cancer; 1997 Jun; 79(11):2178-85. PubMed ID: 9179065
[TBL] [Abstract][Full Text] [Related]
6. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the ureter: a clinicopathologic study of 49 cases.
Anderström C; Johansson SL; Pettersson S; Wahlqvist L
J Urol; 1989 Aug; 142(2 Pt 1):280-3. PubMed ID: 2486233
[TBL] [Abstract][Full Text] [Related]
8. Oncologic outcomes and survival in pT0 tumors after radical nephroureterectomy for upper tract urothelial carcinoma: results from of a large multicenter international collaborative study.
Rouprêt M; Xylinas E; Colin P; Kluth L; Karakiewicz P; Shariat SF
Eur Urol; 2013 Feb; 63(2):404-5. PubMed ID: 23040206
[No Abstract] [Full Text] [Related]
9. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
[TBL] [Abstract][Full Text] [Related]
10. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
Williams AK; Kassouf W; Chin J; Rendon R; Jacobsen N; Fairey A; Kapoor A; Black P; Lacombe L; Tanguay S; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Izawa JI
Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
[TBL] [Abstract][Full Text] [Related]
12. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study on renal pelvic and ureteral cancer].
Sato E; Ishii A; Kunitomi K; Ishito N; Takamoto H; Araki T
Hinyokika Kiyo; 2002 Dec; 48(12):735-9. PubMed ID: 12613007
[TBL] [Abstract][Full Text] [Related]
14. Primary ureteral carcinoma.
Burger R; Spjut HJ
Urology; 1974 Jul; 4(1):40-3. PubMed ID: 21322981
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment.
Weiss RE
Urology; 2010 Feb; 75(2):333. PubMed ID: 20152483
[No Abstract] [Full Text] [Related]
16. Editorial comment.
Shayegan B
Urology; 2010 Feb; 75(2):332-3. PubMed ID: 20152482
[No Abstract] [Full Text] [Related]
17. Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.
Wirth GJ; Haitel A; Moschini M; Soria F; Klatte T; Hassler MR; Bensalah K; Briganti A; Karam JA; Lotan Y; Margulis V; Raman JD; Remzi M; Rioux-Leclercq N; Robinson BD; Rouprêt M; Wood CG; Shariat SF
World J Urol; 2017 Jun; 35(6):943-949. PubMed ID: 27730305
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the renal pelvis and ureter.
Korkes F; Silveira TS; Castro MG; Cuck G; Fernandes RC; Perez MD
Int Braz J Urol; 2006; 32(6):648-53; discussion 653-5. PubMed ID: 17201942
[TBL] [Abstract][Full Text] [Related]
19. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
20. Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma.
Cho KS; Hong SJ; Cho NH; Choi YD
Urology; 2007 Oct; 70(4):662-6. PubMed ID: 17991533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
